Nipbl Interacts with Zfp609 and the Integrator Complex to Regulate Cortical Neuron Migration by Berg, D.L.C. (Debbie) van den et al.
ArticleNipbl Interacts with Zfp609 and the Integrator
Complex to Regulate Cortical Neuron MigrationHighlightsd Nipbl interacts with the transcription factor Zfp609 and the
Integrator complex
d Nipbl, Zfp609, and Integrator are required for cortical neuron
migration
d Nipbl, Zfp609, and Integrator co-occupy genomic binding
sites independently of cohesin
d Nipbl, Zfp609, and Integrator directly regulate neuronal
migration genesvan den Berg et al., 2017, Neuron 93, 348–361
January 18, 2017 ª 2017 The Authors. Published by Elsevier Inc
http://dx.doi.org/10.1016/j.neuron.2016.11.047Authors
Debbie L.C. van den Berg,
Roberta Azzarelli, Koji Oishi, ...,
Dick H.W. Dekkers,
Jeroen A. Demmers,
Franc¸ois Guillemot
Correspondence
debbie.vandenberg@crick.ac.uk
(D.L.C.v.d.B.),
francois.guillemot@crick.ac.uk (F.G.)
In Brief
NIPBL mutations cause Cornelia de
Lange syndrome, but Nipbl function in
brain development is not well
understood. Van den Berg et al. show that
Nipbl interacts with Zfp609 and the
Integrator complex to transcriptionally
regulate cortical neuron migration..
Neuron
ArticleNipbl Interacts with Zfp609 and the Integrator
Complex to Regulate Cortical Neuron Migration
Debbie L.C. van den Berg,1,* Roberta Azzarelli,1 Koji Oishi,1 Ben Martynoga,1 Noelia Urba´n,1 Dick H.W. Dekkers,2
Jeroen A. Demmers,2 and Franc¸ois Guillemot1,3,*
1The Francis Crick Institute, Mill Hill Laboratory, The Ridgeway, London NW7 1AA, UK
2Center for Proteomics, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, the Netherlands
3Lead Contact
*Correspondence: debbie.vandenberg@crick.ac.uk (D.L.C.v.d.B.), francois.guillemot@crick.ac.uk (F.G.)
http://dx.doi.org/10.1016/j.neuron.2016.11.047SUMMARY
Mutations in NIPBL are the most frequent cause of
Cornelia de Lange syndrome (CdLS), a develop-
mental disorder encompassing several neurological
defects, including intellectual disability and seizures.
How NIPBL mutations affect brain development is
not understood. Here we identify Nipbl as a func-
tional interaction partner of the neural transcription
factor Zfp609 in brain development. Depletion of
Zfp609 or Nipbl from cortical neural progenitors
in vivo is detrimental to neuronal migration. Zfp609
and Nipbl overlap at genomic binding sites indepen-
dently of cohesin and regulate genes that control
cortical neuron migration. We find that Zfp609
and Nipbl interact with the Integrator complex,
which functions in RNA polymerase 2 pause release.
Indeed, Zfp609 and Nipbl co-localize at gene
promoters containing paused RNA polymerase 2,
and Integrator similarly regulates neuronal migration.
Our data provide a rationale andmechanistic insights
for the role of Nipbl in the neurological defects asso-
ciated with CdLS.
INTRODUCTION
The cerebral cortex, responsible for higher cognitive function, is
generated from a pool of progenitor cells that will give rise to the
neuronal and glial lineages of the adult brain. Unperturbedmigra-
tion of newly born neurons across the expanding cortex to their
final destination in specific cortical layers ensures accurate
connectivity and neuronal circuit formation. Cell-intrinsic tran-
scription factors play key roles in orchestrating the underlying
molecular processes, as was recently shown for the proneural
transcription factors Neurog2 and Ascl1 (Heng et al., 2008;
Pacary et al., 2011). Developmental disturbance of neuronal
migration affects shaping of the neuronal network and has
been linked to a variety of neurological disorders, including
epilepsy, schizophrenia, autism spectrum disorder (ASD), and
intellectual disability (Guerrini and Parrini, 2010; Muraki and
Tanigaki, 2015; Reiner et al., 2016; Verrotti et al., 2010).348 Neuron 93, 348–361, January 18, 2017 ª 2017 The Authors. Pub
This is an open access article under the CC BY license (http://creativeCornelia de Lange syndrome (CdLS) is one particular example
of a developmental disorder highlighted by neurological defects,
including seizures and intellectual disability. Other characteris-
tics include facial dysmorphism, growth retardation, and upper
limb defects. Heterozygous mutations in the cohesin loading
factor Nipped-B-like (NIPBL) have been identified in 50%–60%
of cases and are associated with a more severe clinical presen-
tation, while mutations in cohesin complex subunits SMC1A,
SMC3, and RAD21 and in the SMC3-targeting deacetylase
HDAC8 account for a further 10% of mostly mildly affected
cases (Braunholz et al., 2015). A genetic cause for the remaining
30% of clinically diagnosed CdLS patients remains unknown.
Despite cohesin complex subunits originally having been iden-
tified for their role in sister chromatid cohesion (Michaelis et al.,
1997), studies have failed to detect overt chromosome segrega-
tion defects in CdLS patients, and instead, deregulated gene
expression is thought to be the prime cause of the observed
developmental abnormalities (Castronovo et al., 2009; Deardorff
et al., 2012; Kawauchi et al., 2009; Liu et al., 2009; Remeseiro
et al., 2013). This likely relates to the ability of cohesin to mediate
long-range chromosome interactions in cis, thereby facilitating
enhancer-promoter looping (Kagey et al., 2010; Nativio et al.,
2009; Seitan et al., 2013).
How Nipbl acts in gene regulatory networks and develop-
mental pathways in brain development is poorly understood. In
this study, we set out to identify new regulators of cortical devel-
opment by studying a mouse ortholog of Drosophila scribbler
(sbb), the single zinc-finger protein Zfp609. We identified Nipbl
as a binding partner of Zfp609, which is specifically expressed
in neural progenitors in the developing mouse cortex. Zfp609
and Nipbl interact and co-bind genomic regions with the RNA
polymerase 2 (RNA pol2)-associated Integrator complex to
directly regulate neuronal migration genes. Accordingly, deple-
tion of Zfp609, Nipbl, or Integrator from cortical progenitors
in vivo results in neuronal migration defects. Our findings define
a Nipbl transcriptional pathway relevant to CdLS.
RESULTS
Zfp609 Is Expressed in Neural Progenitors and
Regulates Cortical Neuron Migration
Zfp608 and Zfp609 are vertebrate homologs ofDrosophila scrib-
bler, a single zinc-finger protein that is highly expressed in the
larval CNS, where it is proposed to act as a transcription factorlished by Elsevier Inc.
commons.org/licenses/by/4.0/).
(Haecker et al., 2007; Yang et al., 2000). Zfp608 is specifically
expressed in the mouse forebrain subventricular (SVZ) and inter-
mediate zone (IZ) at embryonic day (E)14.5 (Ayoub et al., 2011).
To delineate the expression domain of Zfp609, we performed
in situ hybridization on brain sections at different developmental
stages (Figures 1A and S1A, available online). Zfp609 transcripts
are enriched in and subsequently become restricted to the
progenitor population as cortical neurogenesis peaks at E14.5.
The absence of Zfp609 transcripts from cells in the SVZ/IZ at
this stage could be attributed to direct repression by Zfp608,
as occurs in developing thymocytes (Reed et al., 2013). At later
stages of development, Zfp609 expression is detected in the
neurons of the cortical plate (CP) and in stem cells near the ven-
tricular surface.
Because scribbler mutations affect axon targeting and larval
locomotion (Rao et al., 2000; Suster et al., 2004; Yang et al.,
2000), we decided to assess the role of its vertebrate homologs
in brain development. Based on their expression pattern and the
assumption that any disruption to the progenitor population
would affect downstream lineages, we decided to focus our
initial analysis on Zfp609. To address the importance of Zfp609
expression in mouse neural progenitor cells (NPCs) in vivo, we
electroporated short hairpin RNA (shRNA) constructs into
E14.5 mouse embryonic brains (Tabata and Nakajima, 2001).
We designed two independent shRNAs that efficiently deplete
Zfp609 at the transcript and protein level (Figures 1B and S1B).
Each shRNA construct was injected alongwith aGFP expression
vector into the lateral ventricles of E14.5 mouse embryos and
transduced into NPCs near the ventricular surface by a series
of electric pulses. We first analyzed the effect of Zfp609 deple-
tion on progenitor proliferation by labeling dividing cells by
EdU incorporation at E15.5. The fraction of transduced cells
that had exited the cell cycle 24 hr later, identified as labeled
by EdU and negative for Ki67, did not significantly differ between
the two populations (Figures S1C and S1D).
At E14.5, NPCs give rise to upper-layer cortical neurons and,
consistent with this, the majority of control shRNA transduced
neurons were found in superficial positions in the CP at E17.5
(Figures 1C and 1D). In contrast, the neuronal progeny of
Zfp609-depleted NPCs had an abnormal multipolar morphology
and accumulated in the IZ, a phenotype that was confirmed by
an independent Zfp609-targeting shRNA (Figures 1C–1F, S1E,
and S1F). Zfp609-deficient neurons that reached the CP ac-
quired a bipolar morphology, and neither apical dendrites nor
axonal length or projection toward the midline were affected
(Figures S1G–S1J). Strikingly, heterotopic cell clusters were
observed in the white matter of postnatal Zfp609 knockdown
(KD) mice (Zfp609 KD, 2/3 mice; control, 0/3 mice; Figure 1G).
To further rule out that the aberrant neuronal positioning is due
to off-target effects of the shRNAs, we generated an shRNA-
resistant Zfp609 construct harboring three silent mutations,
designated Zfp609* (Figure 1B). Co-electroporation of Zfp609*
fully rescued the IZ accumulation observed for Zfp609-depleted
cells (Figures 1C and 1D). Taken together, these data suggest
that Zfp609 plays a crucial role in the regulation of cortical neuron
migration, which cannot be compensated for by Zfp608.
Neural progenitors can be adherently cultured in vitro and form
a valuable model system to study molecular mechanisms ofneural stem cell (NSC) identity and differentiation, as their limit-
less expansion enables generation of sufficient material for pro-
teomics studies and other genome-wide approaches. To explore
whether they could be used as a tool to study Zfp609 function,
we analyzed Zfp609 transcript and protein levels in embryonic
stem cell (ESC)-derived NSCs (Conti et al., 2005). Consistent
with the in vivo expression pattern, RNA sequencing (RNA-seq)
data showed preferential expression of Zfp609 over Zfp608 (Fig-
ure 1H). We generated an antibody that specifically recognizes
Zfp609 (Figures S1K and S1L) and could detect Zfp609 protein
in NSC lysates (Figure 1H). Immunocytochemistry on NSCs
expressing V5-tagged Zfp609 showed an exclusively nuclear
localization, fitting with its proposed role as a transcription factor
(Figure 1I).
Nipbl Is an Interaction Partner of Zfp609 and Regulates
Neuronal Migration
To gain insight into the molecular environment of Zfp609, we pu-
rified Zfp609 from NSCs and identified its interaction partners by
mass spectrometry. Nuclear extracts from NSCs expressing
doxycycline-inducible V5-tagged Zfp609 were subjected to V5
affinity purification, and Zfp609-containing protein complexes
were separated by SDS-PAA gel electrophoresis (Figure 2A).
NSCs not expressing Zfp609-V5 were used as a control and
benzonase nuclease was added to eliminate DNA-mediated
interactions. Colloidal Coomassie staining of Zfp609-V5 immu-
noprecipitates showed a prominent band at around 150 kD
that reacts with V5 antibody (Figure 2B) and many additional
bands not detected in the control purification, probably repre-
senting Zfp609-interacting proteins.
Gel lanes of Zfp609-V5 and control purifications were
analyzed by mass spectrometry, and interaction partners pre-
sent in two Zfp609 purifications are listed in Table 1. Mascot
scores, emPAI (exponentially modified protein abundance index)
scores, a semiquantitative measure (Ishihama et al., 2005), and
numbers of identified unique peptides of the replicate samples
are shown in Table S1. Interestingly, the cohesin complex,
comprised of Smc1a, Smc3, Rad21, and Stag2, and its loading
factor Nipbl/Mau2 were highly enriched in Zfp609-V5 fractions.
Western blot analysis on Zfp609-V5 immunoprecipitates indeed
confirmed co-purification of Smc1 and Nipbl (Figure 2C). Neither
benzonase nor ethidium bromide affected this interaction, sug-
gesting it occurs independently of DNA. Furthermore, by anti-
body immunoprecipitation we could show the interaction of
endogenous Nipbl and Zfp609 (Figure 2D). Very little Smc1
was detected in these Nipbl immunoprecipitations, indicating
that soluble cohesin at endogenous levels is a substoichiometric
interactor of Nipbl and Zfp609 (Figure S2A). Finally, to identify
the protein domains involved in a direct interaction between
Zfp609 and Nipbl, we expressed GST-fusion proteins represent-
ing partially overlapping domains of Zfp609 in bacteria (Figures
S2B and S2C). GST pull-downs on NSC nuclear extract mapped
the interaction with Nipbl to the N-terminal part of Zfp609, which
also includes the most highly conserved region. The C2H2 zinc-
finger domain by itself was not sufficient for Nipbl binding.
Analogous to Zfp609,Nipbl transcripts are enriched in the ven-
tricular zone at E14.5 (Figure S2D). Our identified direct physical
association between Zfp609 and Nipbl/cohesin may suggestNeuron 93, 348–361, January 18, 2017 349
A B
C D
E F
H I
G
Figure 1. Zfp609 Is Expressed in Neural Progenitors and Regulates Cortical Neuron Migration
(A) Composite bright field images of in situ hybridization on cortical cryosections at indicated stages of mouse development. Scale bar represents 200 mm.
(B) Western blot with indicated antibodies on HEK293T lysates transiently transfected with wild-type or shRNA-resistant (*) Zfp609-V5 expression constructs and
control or Zfp609-targeting shRNA. Lamin B1 was used as a loading control.
(C) Cryosections of mouse embryonic brains in utero electroporated with Zfp609-targeting shRNAs and Zfp609*-V5 rescue construct, stained with GFP to
visualize transfected cells. Ventricular (VZ), subventricular (SVZ), and intermediate zones (IZ) and cortical plate (CP) are indicated. Scale bar represents 100 mm.
(D) Quantification of (C) showing percentage of GFP-expressing cells in indicated cortical regions. Error bars represent SEM, *p < 0.05, ***p < 0.001; ns, non
significant; two-tailed unpaired Student’s t test, n = 7.
(E) Representative images showing morphology of electroporated neurons at E17.5 near the border between IZ and CP. Arrowheads point to multipolar cells;
higher magnification in inset. Scale bar represents 20 mm.
(F)Quantificationof cellmorphology inupper IZ.Errorbars representSEM, *p<0.05, two-tailedunpairedStudent’s t test, n=7 (control shRNA)and8 (Zfp609shRNA).
(G) Representative images of cryosections of electroporatedmouse embryonic brains at postnatal day 2, stainedwithGFP antibody. Scale bar represents 100 mm.
(H) Normalized expression levels in fragments per kilobase of exon per million mapped reads (FPKM) of Zfp608 and Zfp609 transcripts in NSCs. Western blot
analysis of NSC lysate with Zfp609 antibody. Lamin B1 was used as a loading control.
(I) Immunocytochemistry with V5 antibody on NSCs showing nuclear localization of ectopically expressed Zfp609-V5.
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Figure 2. Nipbl Interacts with Zfp609 and Regulates Neuronal Migration
(A) Colloidal Coomassie-stained SDS-PAA gel of Zfp609-V5 and control purification. Zfp609-V5 band is indicated by an arrow. Bands representing antibody
heavy and light chain are indicated by an asterisk.
(B) Western blot with V5 antibody on input, supernatant, and bound fractions of V5 affinity purification.
(C) Western blot with indicated antibodies on V5 immunoprecipitates from Zfp609-V5-expressing NSCs. Benzonase (B) or ethidium bromide (EB) was added as
indicated. Normal mouse IgG was used as control.
(D) Western blot with indicated antibodies on Nipbl immunoprecipitates. Benzonase or ethidium bromide was added as indicated. Normal mouse IgG was used
as control.
(E) Western blot analysis with Nipbl antibody on GST pull-down fractions from NSC nuclear extract using GST-Zfp609 N-terminal (N), middle (M), and C-terminal
(C) fragments or GST control.
(F) Cryosections of mouse embryonic brains in utero electroporated with indicated Nipbl-targeting shRNAs, stained with GFP to visualize transfected cells.
Ventricular (VZ), subventricular (SVZ), and intermediate zones (IZ) and cortical plate (CP) are indicated. Scale bar represents 100 mm.
(G) Quantification of (F) showing percentage of GFP-expressing cells in indicated cortical regions. Error bars represent SEM, *p < 0.05, **p < 0.01, two-tailed
unpaired Student’s t test, n = 4.
(H) Quantification of cell morphology in upper IZ. Error bars represent SEM, **p < 0.01, two-tailed unpaired Student’s t test, n = 4 (control, Nipbl shRNA 1) and
5 (Nipbl shRNA 2).
(I) Representative images of cryosections of electroporatedmouse embryonic brains at postnatal day 2, stained with GFP antibody. Scale bar represents 100 mm.
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Table 1. Zfp609-Interacting Proteins as Identified by Mass
Spectrometry
Protein
Name
Accession
Number Mascota emPAIb
Unique
Peptidesc
Zfp609 UniProt: Q8BZ47 4,314 19.29 71
Cohesin Complex
Nipbl UniProt: Q6KCD5 2,955 1.57 63
Smc3 UniProt: Q9CW03 2,078 3.66 41
Smc1a UniProt: Q9CU62 2,048 3.81 44
Stag2 UniProt: A2AFF6 760 0.65 16
Rad21 UniProt: Q61550 732 1.66 17
Mau2 UniProt: Q9D2X5 406 0.86 9
Integrator Complex
Ints1 UniProt: K3W4P2 2,910 2.28 63
Ints6 UniProt: Q6PCM2 1,834 3.99 36
Ints3 UniProt: Q7TPD0 1,714 2.44 32
Ints7 UniProt: Q7TQK1 1,522 2.28 27
Asun UniProt: Q8QZV7 1,451 5.81 29
Ints5 UniProt: Q8CHT3 993 1.22 19
Ints2 UniProt: Q80UK8 992 0.83 19
Cpsf3l UniProt: Q9CWS4 869 2.34 19
Vwa9 UniProt: Q8R3P6 712 1.60 14
Ints8 UniProt: Q80V86 746 0.90 17
Ints9 UniProt: Q8K114 579 1.36 15
Ints12 UniProt: Q9D168 575 1.68 11
Nabp2 UniProt: E9Q199 75 0.25 2
Transcription Factors
Rfx4 UniProt: Q7TNK1 760 1.30 18
Zbtb20 UniProt: Q8K0L9 622 0.77 11
Other
Maged1 UniProt: Q9QYH6 824 1.10 16
Hspa2 UniProt: P17156 771 1.40 14
Dnaja2 UniProt: Q9QYJ0 312 0.73 7
Stub1 UniProt: Q9WUD1 287 1.30 8
Akap8l UniProt: Q9R0L7 235 0.30 5
Bag5 UniProt: Q8CI32 205 0.50 6
Cnp UniProt: P16330 164 0.34 4
Setx UniProt: A2AKX3 120 0.04 3
Mlf2 UniProt: Q99KX1 108 0.43 3
Zcchc11 UniProt: A2A8R7 86 0.06 3
aAverage Mascot score for the specified protein in two replicate Zfp609-
V5 samples.
bAverage emPAI score for the specified protein in two replicate Zfp609-
V5 samples.
cAverage number of unique, non-redundant peptides for the specified
protein in the Zfp609-V5 sample.they act together in the cell and therefore mediate the same
phenotype. Accordingly, we assessed the effect of Nipbl
depletion on neuronal migration in E14.5 NPCs. Each of two
independent shRNA constructs that resulted in over 50% reduc-
tion in Nipbl transcript levels caused significant accumulation352 Neuron 93, 348–361, January 18, 2017of targeted cells in the IZ 3 days after electroporation, accompa-
nied by a reduction of cell numbers in theCP (Figures 2F, 2G, and
S2E). Arrested neurons had an atypical multipolar morphology
and resulted in white matter heterotopias at postnatal stages
(3/5 mice; Figures 2H and 2I). Other aspects of neurogenesis
were not notably affected by Nipbl depletion (Figures S1G–
S1I). We conclude that Zfp609 and Nipbl physically interact
and regulate the same cellular process during mouse forebrain
development.
Zfp609 and Nipbl Co-occupy Active Promoter and
Enhancer Regions
To assess if Zfp609 andNipblmay cause the same phenotype by
cooperating in regulating target genes, we first determined
genomic binding sites for both factors in cultured NSCs. Chro-
matin immunoprecipitations of ectopically expressed Zfp609-
V5 and endogenous Nipbl (Figures S3A and S3B) were analyzed
by high-throughput sequencing of bound DNA (ChIP-seq).
Two independent biological replicates correlated well (Pearson
r > 0.9) and samples were pooled for further analysis. We identi-
fied 24,064 Zfp609 and 27,874 Nipbl genomic binding sites.
Zfp609 and Nipbl showed a strikingly high (65%–75%) overlap
in binding sites (Figure 3A). Zfp609 binding signal corresponded
well to that of Nipbl (Figure S3C).
We reanalyzed published data on genome-wide binding
profiles of cohesin subunit Smc1 and CTCF in NSCs (Phillips-
Cremins et al., 2013). Previously, cohesin sites in enhancer and
promoter regions were demonstrated to also be bound by Nipbl
and theMediator complex in ESCs (Kagey et al., 2010).We found
that binding sites of Nipbl and Zfp609 hardly overlap with Smc1,
while Smc1 and CTCF binding sites did extensively overlap in
NSCs (Figures 3A, S3C, and S3D). A similar discrepancy be-
tween the genomic localization of cohesin and its loading factor
was recently reported in human mammary epithelial HB2 cells
(Zuin et al., 2014). Our results cannot be attributed to differences
in antibody epitope or performance, as the antibody was iden-
tical to the one used for ChIP-seq in ESCs (Kagey et al., 2010).
This suggests that also in NSCs, Nipbl can have a cohesin-inde-
pendent role in transcription regulation.
Compared to cohesin, CTCF, and other NSC transcription fac-
tors (Figure 3B; Mateo et al., 2015), Nipbl and Zfp609 have a
preference for promoter regions, with 30%–39% of binding sites
mapping in a window from 1 kb to +1 kb around transcription
start sites (TSSs). We examined the chromatin landscape sur-
rounding Zfp609 and Nipbl binding sites by profiling their binding
intensity to a catalog of NSC regulatory elements compiled
based on histone modification patterns surrounding DNaseI
hypersensitive sites (DHSs) (Mateo et al., 2015). We found
that Nipbl and Zfp609 predominantly localize to active and
poised proximal and distal DHS clusters, hallmarked by the pres-
ence of H3K27ac and by the absence of H3K27 post-transla-
tional modification, respectively (Figures 3C and 3D). Nipbl and
Zfp609 promoter-bound genes have an above-average expres-
sion level (Figure 3E). In contrast, Smc1 and CTCF binding was
mostly detected at DHSs that were not marked by any of the
assessed histone modifications (Figures 3C and 3D).
Motif discovery analysis using MEME-ChIP (Machanick and
Bailey, 2011) detected enrichment of consensus sites for Sp1
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Figure 3. Zfp609 and Nipbl Co-localize to Active Promoter and Enhancer Regions
(A) Venn diagram showing overlap of Zfp609, Nipbl, and Smc1 bound regions.
(B) Distribution of Zfp609, Nipbl, Zfp609/Nipbl common, Smc1, and CTCF genomic binding sites to promoters (1 kb to +1 kb)and intra- and intergenic regions.
(C) Heatmap of 7,030 active H3K4me3, H3K27ac-marked; 1,498 poised H3K4me1/me2-marked; 690 repressed H3K4me2, H3K27me3-marked; and 1,573
unmarked promoter proximal DNaseI hypersensitive (DHS) sites centered around DHS summits. Regions are ranked by normalized Zfp609 ChIP-seq signal, and
mean ChIP-seq counts of indicated factors are plotted.
(D) Heatmap of 3,912 active H3K4me1, H3K27ac-marked; 6,487 poised H3K4me1-marked; 866 repressed H3K4me1, H3K27me3-marked; and 3,714 unmarked
distal DHSs displaying 10 kb region around DHS summit. Regions are ranked by normalized Zfp609 ChIP-seq signal, and mean ChIP-seq counts of indicated
factors are plotted.
(legend continued on next page)
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and the Ets family transcription factor Elk4 in proximal DHSs
bound by Zfp609 and Nipbl (Figure 3F). These motifs are
commonly found in promoter regions (Mateo et al., 2015) and,
apart from the bimodal distribution of Elk4 motifs flanking Nipbl
sites, are not centrally enriched in Zfp609 or Nipbl peaks (Fig-
ure S3E), suggesting that Zfp609 or Nipbl is not targeted to pro-
moter regions by sequence-specific transcription factors. E-box
motifs recognized by bHLH transcription factors are highly abun-
dant in active enhancer elements (Mateo et al., 2015) and were
significantly enriched at the center of distal Zfp609 and Nipbl
peaks (Figures 3G and S3F). In addition, we found a significant
central enrichment for nuclear factor I (Nfi) and Rfx motifs. Rfx4
was detected as a Zfp609 co-purifying factor bymass spectrom-
etry (Table 1), and although this approach did not identify bHLH
transcription factors, we were able to demonstrate a specific
DNA-independent interaction between V5-Ascl1 and FLAG-
tagged Zfp609 (Figure S3G). Rfx and bHLH factors therefore
constitute candidate-targeting factors for Zfp609 and Nipbl to
distal regulatory elements.
Zfp609 and Nipbl Regulate Neuronal Migration Genes
To identify Nipbl and Zfp609 target genes that could account for
the neuronal migration defects observed in vivo, we depleted
both factors individually fromNSCs by RNAi and identified differ-
entially expressed genes by RNA-seq (Figures 4A, 4B, S4A, and
S4B). Nipbl and Zfp609 KD significantly affected the expression
of 3,748 and 1,103 genes, respectively. Amuch higher fraction of
genes than would be expected by chance were deregulated in
both KD conditions (n = 619, p = 3.103 10215, hypergeometric
test). Out of these, 83% changed expression in the same direc-
tion, suggesting cooperativity between Nipbl and Zfp609 in gene
regulation. We subsequently focused our analysis on shared
target genes of Nipbl and Zfp609, postulated as bound and regu-
lated by both factors. To associate genes with Nipbl and Zfp609
binding sites, we used GREAT (Genomic Regions Enrichment of
Annotations Tool) (McLean et al., 2010), which assigns to each
gene a basal regulatory domain from 5 kb to +1 kb, extending
up to 1 Mb to the next neighboring basal regulatory domains.
Intersection of thus-determined bound genes with deregulated
genes resulted in the identification of 490 target genes down-
stream of both Zfp609 and Nipbl (Figure 4C). A total of 398 target
genes were misregulated in parallel, with 244 genes activated
and 154 genes repressed by both factors.
Gene ontology (GO) analysis on these two categories of
Zfp609/Nipbl target genes revealed enrichment for terms related
to cell motion and the extensive cytoskeletal remodeling that
occurs during this process (‘‘cell projection organization,’’ ‘‘regu-
lation of neuron projection development,’’ and ‘‘regulation of
axogenesis’’), in particular among the set of target genes acti-
vated by Nipbl and Zfp609 (Figures 4D and 4E). Similar GO terms
were enriched among putative Zfp609 target genes that were
also deregulated in E13.5 Nipbl+/ brains (Figures S4C and
S4D) (Kawauchi et al., 2009). We focused in more detail on a(E) Violin plot showing distribution of log2 transformed absolute expression value
Nipbl. White dot indicates the median and thick black bar represents the interqu
(F) Top two most significantly enriched motifs in Zfp609 and Nipbl proximal bind
(G) Top two most significantly enriched motifs in distal Zfp609 and Nipbl peaks.
354 Neuron 93, 348–361, January 18, 2017subset of genes (i.e., Sema3a,Nrp1, Plxnd1, andGabbr2) whose
downregulation is known to cause neuronal migration defects.
Sema3a is a secreted chemoattractive guidance molecule pre-
sent in a descending gradient from the CP that acts through
the co-receptor neuropilin-1 (Nrp1) and specific Plexin recep-
tors, including PlexinD1 (Plxnd1), to promote radial migration
of cortical neurons (Chen et al., 2008). Disruption of the gradient
or downregulation of either Nrp1 or Plxnd1 results in mislocaliza-
tion of cells to lower cortical regions (VZ/SVZ/IZ). In addition,
non-hyperpolarizing signaling through GABAB receptors was
shown to be required for cell transition from the IZ to the CP
in vitro and in vivo (Behar et al., 2000, 2001; Bony et al., 2013).
Indeed, we could detect Zfp609 and Nipbl binding to promoter
and intragenic regions of Sema3a, Nrp1, Plxnd1, and Gabbr2,
and depletion of Nipbl or Zfp609 reduced expression of these
targets in NSCs (Figures 4F–4H). We therefore conclude that
Zfp609 and Nipbl co-regulate genes required for cortical neuron
migration.
Zfp609 and Nipbl Interact with Integrator to Regulate
Migration Genes
The binding of Zfp609 and Nipbl to active promoter regions sug-
gests they may directly contact the basal transcription machin-
ery to activate transcription. Although we did not consistently
detect RNA pol2 subunits in Zfp609 pull-downs, we did find
thirteen subunits of the Integrator complex, which associates
with the C-terminal domain (CTD) of RNA pol2 (Malovannaya
et al., 2010) (Table 1). Specificity of the interaction of Zfp609
with the Ints1 subunit was demonstrated by detection of Ints1
by immunoblotting in the Zfp609-V5 sample and not in the
control (Figure 5A).
The interaction of endogenous Zfp609, Nipbl, and Integrator
complex was independently verified by their co-immunoprecip-
itation by an antibody against Ints1. Immunoblotting showed
specific co-purification of Zfp609 and Nipbl, independent of
DNA (Figure 5B). Western blotting with an antibody against
Ints11 (Cpsf3l) was used as a positive control. GST pull-downs
mapped the interaction domain with Integrator to the N-terminal
region of Zfp609, which also brought downRNA pol2 (Figure 5C).
We determined the genomic distribution of Integrator binding
by performing ChIP-seq with an antibody that efficiently brought
down chromatin-bound Ints11 (Figure S5A). Three independent
replicates correlated well (Pearson r > 0.86) and were pooled
for downstream analysis. Consistent with published reports
from HeLa cells, we detected widespread binding to promoter
and predominantly active enhancer regions, where Integrator
strongly co-localizes with Zfp609 and Nipbl (Figures 5D, 5E,
and S5C) (Gardini et al., 2014; Lai et al., 2015). For comparison,
we included genome-wide ChIP-seq data for RNA pol2, showing
its preferential binding to active promoter regions (Figures 5D,
5E, and S5B).
Integrator was recently shown to physically associate with
negative elongation factor (NELF) and the DRB-sensitivitys of genes either bound or not bound in their promoter region by Zfp609 and
artile range. p value by Mann-Whitney test is indicated.
ing peaks. Enrichment values as reported by Centrimo are listed.
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Figure 4. Zfp609 and Nipbl Regulate Neuronal Migration Genes
(A) Western blot with Zfp609 antibody on NSC lysates lentivirally transduced with control or Zfp609-targeting shRNA. Actin was used as a loading control.
(B) Western blot with Nipbl antibody on NSC lysates lentivirally transduced with control or Nipbl-targeting shRNA. Vcp was used as a loading control.
(C) Venn diagram showing intersection of genes bound in their regulatory region (basal 5 kb to +1 kb plus extension up to 1 Mb, GREAT) and transcriptionally
regulated by Zfp609 and Nipbl.
(D) GO analysis on genes bound and activated by Zfp609 and Nipbl. DAVID p values are shown, FDR < 5%.
(E) GO analysis on genes bound and repressed by Zfp609 and Nipbl. DAVID p values are shown, FDR < 5%.
(legend continued on next page)
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inducing factor (DSIF) complex and to affect RNA pol2 pause
release at coding genes (Gardini et al., 2014; Skaar et al.,
2015; Stadelmayer et al., 2014; Yamamoto et al., 2014). We
therefore asked whether paused RNA pol2 also constitutes a
key feature of genes containing Zfp609 and Nipbl binding sites
in their promoter proximal regions. Indeed, when we compared
RNA pol2 pausing indices of Zfp609/Nipbl-bound versus all
non-bound expressed genes (fragments per kilobase of tran-
script per million mapped reads [FPKM] > 1), we could detect
significantly increased pausing at Zfp609/Nipbl promoter-bound
genes (Figure 5F).
To determine genes co-regulated by Zfp609, Nipbl, and
Integrator, we performed RNA-seq analysis on NSCs depleted
for Integrator subunits Ints1 and Ints11 by RNAi (Figures 5G
and S5D). All of the 142 common putative target genes were
deregulated in the same direction by either Ints1 or Ints11 KD,
suggesting both factors function agonistically within the Inte-
grator complex (data not shown). Integrator-regulated genes
were pooled and compared to the previously classified set
of Nipbl and Zfp609 target genes (Figure 5H). In total, 85% of
common deregulated genes changed expression in the same di-
rection upon either Zfp609/Nipbl or Integrator KD, suggesting
functional cooperativity. Two-thirds of these were downregu-
lated in all KD conditions. Three out of the four genes that we pre-
viously implicated in the regulation of cortical neuron migration
downstream of Zfp609 and Nipbl, i.e., Sema3a, Plxnd1, and
Gabbr2, were downregulated upon Ints1 depletion (Figure 5I).
Importantly, compromising Integrator complex function by in
utero electroporation of either Ints1- or Ints11-targeting shRNAs
also resulted in an abnormal accumulation of cells in the IZ (Fig-
ures 5J and 5K). We therefore conclude that Zfp609 and Nipbl
act with the Integrator complex to positively regulate common
target genes and thereby promote neuronal migration.
DISCUSSION
In an unbiased proteomics approach, we identified physical in-
teractions between Zfp609, cohesin, and the cohesin loading
factor Nipbl/Mau2. We show that in mice, the two Drosophila
scribbler homologs Zfp608 and Zfp609 are expressed in the
embryonic forebrain in a mutually exclusive manner, possibly
through direct cross-repression, analogous to what was re-
ported in developing thymocytes (Reed et al., 2013). Indeed,
we find that Zfp609 and Nipbl bind to the Zfp608 promoter in
NSCs to silence its transcription. Interestingly, elevated Zfp608
expression was identified as one of three biomarkers that could
accurately distinguish CdLS probands from healthy control
individuals (Liu et al., 2009), implicating these factors and their
interrelationship in the establishment of CdLS.
We mapped the genomic binding sites of Zfp609 and Nipbl in
NSCs to predominantly active promoter and enhancer regions,(F) UCSC browser tracks displaying normalized Nipbl and Zfp609 ChIP-seq signal
are indicated on a separate line.
(G) qPCR analysis on NSCs lentivirally transduced with control or Zfp609-targetin
t test corrected for multiple comparisons using Holm-Sidak method, n = 3.
(H) qPCR analysis on NSCs lentivirally transduced with control or Nipbl-targetin
corrected for multiple comparisons using Holm-Sidak method, n = 3.
356 Neuron 93, 348–361, January 18, 2017similar to the genomic distribution of Nipbl in ESCs (Kagey
et al., 2010). Contrary to ESCs and despite the significantly
higher number of Nipbl peaks identified here, very fewNipbl sites
were co-occupied by cohesin. Instead, cohesin almost exclu-
sively localizes to CTCF sites, perhaps as a consequence of co-
hesin sliding, analogous to reports in yeast (Lengronne et al.,
2004). This discrepancy between ESCs and NSCs therefore
may reflect a difference in cell-cycle length or cohesin dynamics,
which impact the frequency of cohesin complex reloading. Inter-
estingly, a similar disparity in Nipbl and cohesin localization was
noted in human breast epithelial cells, which, in combination with
differential effects on gene expression, led the authors to pro-
pose a cohesin-independent role for Nipbl in gene regulation
(Zuin et al., 2014). How Nipbl would act as a transcription factor
remained unclear. We now provide evidence that Nipbl contacts
the Integrator complex associated with the RNA pol2 CTD,
possibly via Zfp609.
Genome-wide ChIP-seq analysis demonstrated that virtually
all active and 50% of poised NSC promoters are bound by Inte-
grator, where it often co-localizes with Zfp609/Nipbl. Integrator
interacts with the pause-inducing factors NELF and DSIF and
occupies promoters containing paused RNA pol2 in HeLa cells
(Stadelmayer et al., 2014). Similarly, Zfp609 and Nipbl-bound
NSC promoters are characterized by a higher mean RNA pol2
pausing index. RNA pol2 pausing occurs after the first 20–60 nu-
cleotides have been transcribed and provides an additional
mode of regulation for nearly 50% of mammalian genes (Kwak
and Lis, 2013).
The role of Integrator in the regulation of RNA pol2 pausing ap-
pears to be two sided, as it has been shown to be required both
for maintenance of pausing and for transition into productive
elongation (Gardini et al., 2014; Stadelmayer et al., 2014). Inte-
grator promotes RNA pol2 release at immediate early genes in
HeLa cells by recruiting the super elongation complex (SEC),
containing AFF4 and the most active form of positive transcrip-
tion elongation factor P-TEFb (Luo et al., 2012). De novo gain-
of-function mutations in AFF4 were recently identified in three
patients with a new syndrome, CHOPS (cognitive development
and coarse facies, heart defects, obesity, pulmonary involve-
ment, short stature, and skeletal dysplasia), that displays
phenotypic overlap with CdLS (Izumi et al., 2015). We provide
biochemical evidence for a link between the most frequently
mutated gene in CdLS, NIPBL, and the AFF4-containing SEC,
implicating the regulation of transcription elongation in the
ontogeny of CdLS abnormalities.
We show that depletion of Zfp609, Nipbl, or Integrator in vivo
results in aberrant neuronal migration and postulate that the
deregulated expression of their target genes involved in sema-
phorin and GABA signaling is likely to be responsible for this
phenotype. Zfp609 and Nipbl transcripts are mostly present in
the VZ/SVZ, while themigration arrest occurs in the IZ. This delayin intragenic and promoter regions of indicated genes. Significant called peaks
g shRNA. Error bars represent SEM, *p < 0.05, **p < 0.01, unpaired Student’s
g shRNA. Error bars represent SEM, ****p < 0.0001, unpaired Student’s t test
A B C
D E
F G H
I J
K
(legend on next page)
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could reflect a requirement for Zfp609 and Nipbl to establish
and maintain accessibility of genomic binding sites to other
regulatory factors. Alternatively, Zfp609 and Nipbl protein
expression might be maintained in postmitotic neurons after
downregulation of their respective transcripts.
Defects in neuronal migration and the subsequent incorrect
neuronal positioning lead to disruption of neural circuit forma-
tion and have been causally linked to intellectual disability
and seizures, which are both features of CdLS (Liu and Krantz,
2009; Verrotti et al., 2013). Indeed, neuronal heterotopias were
reported in autopsy data of CdLS patients (Tekin and Bodurtha,
2015). Abnormal localization of E13.5-born neurons in the IZ
was also observed in mice carrying a heterozygous mutation
in Ankrd11, a chromatin regulator mutated in rare cases of
CdLS (Gallagher et al., 2015; Parenti et al., 2016). Furthermore,
our data suggest that Zfp609 and Nipbl act through the Inte-
grator complex to contact the basal transcription machinery
and regulate gene expression at the level of RNA pol2 pause
release. Embryonic brain KD of Phf6 or its interactor Paf1, a
recently identified regulator of promoter-proximal RNA pol2
pausing, resulted in aberrant neuronal accumulation in the
IZ caused by downregulation of Cspg5, a transmembrane
glycoprotein of the neuregulin family (Chen et al., 2015; Zhang
et al., 2013). Importantly, mutations in PHF6 cause Bo¨rjeson-
Forssman-Lehmann syndrome (BFLS), characterized by mod-
erate-to-severe intellectual disability and seizures (Lower
et al., 2002). Together with our data, this suggests a prominent
role for the regulation of RNA pol2 pause release in the con-
trol of neuronal migration, which ultimately impacts cognitive
function.
By studying Nipbl function in neural progenitors in vitro and
in vivo, we have generated a deeper understanding of its gene
regulatory network and uncovered a role in the control of
neuronal migration, which, when perturbed, is likely to contribute
to the cognitive impairment of CdLS patients. Our description of
the molecular machinery involved in transcription regulation by
Nipbl in neural progenitors offers a range of candidates for mu-
tation screening in the 30% of CdLS cases where no causative
mutation has been identified.Figure 5. Zfp609 and Nipbl Interact with Integrator to Regulate Cortica
(A) Western blot with indicated antibodies of V5 immunoprecipitates on Zfp609-V
(B) Immunoprecipitation of Ints1 analyzed by western blot with indicated antibod
anti-GFP was used as control.
(C) GST pull-down with Zfp609 N-terminal (N), middle (M), and C-terminal (C) fra
indicated antibodies.
(D) Heatmap of 7,030 active, 1,498 poised, 690 repressed, and 1,573 unmarked
ranked by normalized Zfp609 ChIP-seq signal, and mean ChIP-seq counts of ind
(E) Heatmap of 3,912 active, 6,487 poised, 866 repressed, and 3,714 unmarked d
normalized Zfp609 ChIP-seq signal, and mean ChIP-seq counts of indicated fac
(F) Boxplot representing distribution of pausing indices of Zfp609 TSS-bound (n
represent minimum and maximum values. p value by Mann-Whitney test is indic
(G) Western blot on NSC lysates lentivirally transduced with the indicated shRNA
(H) Venn diagram displaying intersection of deregulated genes in Integrator KD w
(I) Normalized expression values from RNA-seq data on control or Ints1-deplet
corrected for multiple comparisons using Holm-Sidak method, n = 3.
(J) Cryosections of mouse embryonic brains in utero electroporated with Ints1- a
cells. Ventricular (VZ), subventricular (SVZ), and intermediate zones (IZ) and cort
(K) Quantification of (J) showing percentage of GFP-expressing cells in indicate
Student’s t test corrected for multiple comparisons using Holm-Sidak method, n
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Cell Culture
NS5 NSCs were grown on laminin-coated dishes as previously described
(Conti et al., 2005). To generate inducible V5-tagged Zfp609-expressing
NSCs, the coding sequence of Zfp609 fused to a C-terminal V5 tag was in-
serted into lentiviral plasmid Tet-O-FUW-EGFP (kind gift from Marius Wernig,
Addgene #30130; Vierbuchen et al., 2010) in place of eGFP. Lentiviral particles
were produced by co-transfection with psPax2 and pMD2.G (kind gifts from
Didier Trono, Addgene #12260 and #12259) in HEK293T cells and concen-
trated by ultracentrifugation. NSCs were simultaneously transduced with len-
tiviruses for Zfp609-V5 and rtTA (kind gift from Rudolf Jaenisch, Addgene
#20342; Hockemeyer et al., 2008). Expression of Zfp609-V5 was induced for
a minimum of 6 hr by addition of 1 mg/mL doxycycline (Sigma). HEK293T
and P19 cells in standard culture conditions were transiently transfected using
Lipofectamine 2000 transfection reagent (Invitrogen).
Antibodies
Zfp609 antibodies were generated in guinea pigs against recombinantly ex-
pressed Zfp609 (aa 1–282) fused to GST. Normal mouse IgG (sc-2025), normal
rabbit IgG (sc-2027), and antibodies against Lamin B1 (sc-6216 and sc-6217),
RNA pol2 (sc-899), and GFP (sc-8334) were obtained from Santa Cruz
Biotechnology. Antibodies against Smc1 (A300-055A), Nipbl (A301-779A),
Int1 (A300-361A), and Int11 (A301-274A) were obtained from Bethyl Labora-
tories. Additional antibodies included V5 (R960-25, Invitrogen), Actin (A2066,
Sigma), Vcp (ab11433, Abcam), and GFP (4745-1051, AbD Serotec).
Protein Purification
Control and Zfp609-V5-expressing NSCs were expanded to ten confluent
14 cm diameter dishes (2 3 108 cells) and scraped in ice-cold PBS, and nu-
clear extracts were prepared (Dignam et al., 1983) and diluted to 100 mM
NaCl with C-0 (20 mM HEPES [pH 7.6], 0.2 mM EDTA, 1.5 mM MgCl2, and
20% glycerol). Complete EDTA-free protease inhibitors (Roche) were added
to all buffers. A total of 40 mL anti-V5 agarose beads (Sigma) were equilibrated
in buffer C-100* (20 mM HEPES [pH 7.6], 100 mM KCl, 0.2 mM EDTA, 1.5 mM
MgCl2, 0.02% NP-40, and 20% glycerol); blocked in 0.2 mg/mL chicken egg
albumin (Sigma), 0.1 mg/mL insulin (Sigma), and 1% fish skin gelatin (Sigma)
in C-100*; and added to 1.5 mL nuclear extract in no stick microtubes (Alpha
Laboratories) for 3 hr at 4C in the presence of 225 U Benzonase (Novagen).
Beads were washed five times for 5 min with C-100* and boiled in 30 mL
SDS loading buffer. Eluted proteins separated by polyacrylamide gel electro-
phoresis were stained with Colloidal Coomassie (Invitrogen), and entire gel
lanes were analyzed by mass spectrometry as previously described (van
den Berg et al., 2010). Criteria for inclusion in Table 1 are presence in both pu-
rifications with a Mascot score of at least 50 and both Mascot and emPAIl Migration
5-expressing or control NSC nuclear extract.
ies. Benzonase (B) or ethidium bromide (EB) was added as indicated. Rabbit
gments or GST control on NSC nuclear extract analyzed by western blot with
promoter proximal DHSs displaying 10 kb around DHS summits. Regions are
icated factors are plotted.
istal DHSs displaying 10 kb region around DHS summit. Regions are ranked by
tors are plotted.
= 5,391) versus all other (n = 1,543) expressed (FPKM > 1) genes. Whiskers
ated.
s. Actin was used as a loading control.
ith Zfp609/Nipbl target genes.
ed NSCs. Error bars represent SEM, ***p < 0.001, unpaired Student’s t test
nd Ints11 (Cpsf3l)-targeting shRNAs, stained with GFP to visualize transfected
ical plate (CP) are indicated. Scale bar represents 100 mm.
d cortical regions. Error bars represent SEM, **p < 0.01, two-tailed unpaired
= 4 (control) and 6 (Ints1 and Ints11 shRNA).
scores at least 3-fold enriched over the corresponding control purification.
Cytoskeletal and cytoplasmic proteins were removed from the analysis. For
small-scale immunoprecipitations, 2.5 mg antibody, 25 mL protein A or protein
G dynabeads, and 200 mL nuclear extract were used. Normal mouse IgG,
rabbit IgG, or anti-GFP antibody served as control, and 25 U Benzonase or
25 mg/mL ethidium bromide were added where indicated.
GST Pull-Down
Zfp609 fragments were cloned into pGEX-2TK. GST-fusion proteins and GST
were expressed in BL21-CodonPlus (DE3)-RP competent cells, and GST pull-
downs were performed as previously described (van den Berg et al., 2010).
RNAi and RNA-Seq
Short hairpin sequences (Table S3) were cloned into pSuper (Oligoengine) for
transient transfections and in utero electroporation purposes. For RNAi in
NSCs, short hairpin sequences were cloned from pENTR/pSUPER+ into
pLentiX1 (kind gifts from Eric Campeau, Addgene #17338 and #17297;
Campeau et al., 2009). Lentiviral particles were produced in HEK293T cells,
concentrated by ultracentrifugation, and used to infect NSCs. Transduced
NSCs were selected for 48 hr with 0.5 mg/mL puromycin starting 24 hr after
transduction, and RNA was extracted using Trizol reagent (Invitrogen) and pu-
rified on RNeasy columns (QIAGEN). Sequencing libraries were prepared ac-
cording to the TruSeqRNASample Preparation v2 kit (Illumina) and sequenced
with the HiSeq 2000 (Illumina). Readswere aligned to themm9mouse genome
with TopHat, and differentially expressed genes listed in Table S2 were iden-
tified with Cuffdiff using default parameters (Trapnell et al., 2012). Primer se-
quences (Table S4) and Taqman probes used for validation by qPCR are listed
in the Supplemental Experimental Procedures. DAVID functional clustering
webtool (Huang et al., 2009) was used for GO analysis setting a false discovery
rate (FDR) < 5%.
ChIP-Seq Analysis and Data Visualization
For V5, Nipbl, and Ints11 ChIP, NSCs suspended in PBS were crosslinked
sequentially for 45 min with 2 mM disuccinimidyl glutarate (DSG) and for
10 min with 1% formaldehyde. Reactions were quenched with 125 mM
glycine, chromatin was prepared, and ChIP performed as described (Boyer
et al., 2005). RNA pol2 ChIP was performed on formaldehyde-crosslinked
chromatin as described (Rahl et al., 2010). Sequencing libraries were prepared
from 2–10 ng ChIP or input control DNA according to Illumina standard ChIP-
SeqSample Prep kit and sequencedwith aGenomeAnalyzer IIx or HiSeq 2000
(Illumina). Reads were aligned to the mm9 mouse genome using Bowtie 2
(Langmead and Salzberg, 2012) with default parameters. Aligned reads were
subsampled with custom python scripts (Mateo et al., 2015) and peaks called
with MACS version 2 (Zhang et al., 2008) setting shift size to 90 and q value to
0.05. ChIP bedGraphs uploaded to UCSC Genome browser mm9 were
normalized to control and converted to bigWig using MACS. Venn diagrams
were generated using Biovenn (Hulsen et al., 2008) and eulerAPE (Micallef
and Rodgers, 2014). Heatmaps were generated from MACS q value bigWig
files using the deepTools package (Ramı´rez et al., 2014). Mean scores of
100 bp bins 10 kb around the peak or DHS summit were displayed. Motif
discovery was performed with MEME-ChIP (Machanick and Bailey, 2011) us-
ing 400 bases around the peak summit as input. RNA pol2 pausing indices
were calculated as the ratio of reads in the TSS proximal region (250
to +250 bp) over reads in the gene body (+500 bp to +2,500 bp). Genes with
no reads in either promoter or gene body region were excluded from the
analysis. Primer sequences used for ChIP-qPCR analysis are listed in the
Supplemental Experimental Procedures.
In Utero Electroporation
Mice were housed, bred, and treated according to guidelines approved by the
Home Office under the Animal (Scientific Procedures) Act 1986. Experiments
were approved by the Crick Animal Welfare and Ethical Review Body and
the Home Office (project license 707644).In utero electroporation was per-
formed essentially as described (Azzarelli et al., 2014). Briefly, 1 mg endofree
plasmid preparations of pSuper shRNA constructs, pcDNA expression vector,
and pCA-b-EGFPm5 silencer3 containing 0.05% Fast Green dye (Sigma) were
injected into the lateral ventricle of E14.5 embryos. Five 30 V electric pulseswere applied at 1 s intervals across the uterine wall using a 5 mm platinum
electrode. Three days after electroporation, embryonic brains were fixed for
1 hr in 4% paraformaldehyde, cryo-protected in 30% sucrose, and embedded
in OCT compound (VWR) containing 30% sucrose. Cryosections (14 mm) were
stained with anti-GFP (AbD Serotec) and Alexa 488 conjugated secondary
antibody and imaged with a confocal microscope. The onset of glia-guided
locomotion was used to define the border between IZ and CP (Heng et al.,
2010). At least 250 GFP-labeled cells per brain, irrespective of GFP level,
were counted blindly; at least four brains were analyzed per condition. The
numbers of uni/bipolar (i.e., one to two primary processes) and multipolar
(i.e., >two primary processes) were quantified in the upper IZ (n R 20) and
CP (nR 70); at least three brains were analyzed per condition.
In Situ Hybridization
Cryosections were post-fixed in 4% paraformaldehyde, treated for 10min with
100 mM acetylated triethanolamine (pH 8.0), and pre-hybridized in hybridiza-
tion buffer (50% formamide, 53 SSC, 5% SDS, and 1 mg/mL yeast tRNA) for
1 hr at 70C. The Zfp609 probe template was PCR amplified from NSC cDNA
(primer sequences in Table S5), in vitro transcribed in the presence of DIG RNA
labeling mix (Roche), purified with RNeasy kit (QIAGEN), denatured, and
hybridized to cryosections in hybridization buffer overnight at 70C. Bound
probes were detected with an alkaline phosphatase-conjugated anti-DIG
antibody (Roche) and NBT/BCIP substrate (Sigma).
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